Company Filing History:
Years Active: 2019-2025
Title: Innovations in Antibiotic Susceptibility Testing by José Luis Fernández García
Introduction
José Luis Fernández García is a notable inventor based in Oleiros, Spain. He has made significant contributions to the field of microbiology, particularly in the rapid determination of bacterial susceptibility to antibiotics. With a total of 3 patents, his work is crucial in addressing the growing concern of antibiotic resistance.
Latest Patents
José Luis Fernández García's latest patents include a "Method for the rapid determination of susceptibility or resistance of bacteria to antibiotics." This innovative method evaluates the susceptibility of bacterial strains to antibiotics that inhibit cell wall synthesis. It is based on assessing cell enlargement in response to specific doses of antibiotics, which are correlated to breakpoints of bacterial susceptibility.
Another significant patent is the "Procedure for the rapid determination of bacterial susceptibility to antibiotics that inhibit protein synthesis." This invention focuses on identifying bacterial responses influenced by protein synthesis. If the antibiotic reduces or prevents these responses, the bacteria are deemed susceptible. Conversely, if the responses remain unchanged, the bacteria are classified as resistant.
Career Highlights
José Luis Fernández García is associated with Abm Technologies, LLC, where he continues to advance research in antibiotic susceptibility testing. His work is pivotal in developing methods that can lead to more effective treatments for bacterial infections.
Collaborations
He collaborates with esteemed colleagues such as Jaime Gosálvez Berenguer and Rebeca Santiso Brandariz, contributing to a dynamic research environment focused on innovative solutions in microbiology.
Conclusion
José Luis Fernández García's contributions to antibiotic susceptibility testing are invaluable in the fight against antibiotic resistance. His innovative methods pave the way for more effective clinical practices and improved patient outcomes.